---
figid: PMC9695027__jpm-12-01819-g003
pmcid: PMC9695027
image_filename: jpm-12-01819-g003.jpg
figure_link: /pmc/articles/PMC9695027/figure/jpm-12-01819-f003/
number: Figure 3
figure_title: ''
caption: 'TRK receptors’ intracellular signaling pathway. The interaction between
  the receptor and the ligand activates crosstalk between multiple intracellular molecular
  cascades. Abbreviations: protein kinase B (AKT); Diacylglycerol (DAG); Extracellular
  signal-regulated kinase (ERk-1); GRB2-Associated Binding Protein-1 (GAB-1); Growth
  Factor Receptor-Bound Protein-2 (GRB-2); Inositol trisphosphate (IP-3); Mitogen-activated
  protein kinase (MEK); Mammalian Target of Rapamycin (m-TOR); Nuclear Factor Kinase-β
  (NF-Kβ); 3-Phosphoinositide-Dependent Protein Kinase-1 (PDK-1); Protein Kinase C
  (PKC); Phospholipase C-γ (PLC-γ); Rapidly Accelerated Fibrosarcoma (RAF); Rat Sarcoma
  virus (RAS); Son of Sevenless (SOS). Created with BioRender.com.'
article_title: 'NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic
  Review of Case Reports and Case Series.'
citation: Giovanni Maria Iannantuono, et al. J Pers Med. 2022 Nov;12(11):1819.
year: '2022'

doi: 10.3390/jpm12111819
journal_title: Journal of Personalized Medicine
journal_nlm_ta: J Pers Med
publisher_name: MDPI

keywords:
- NTRK gene fusions
- TRK inhibitors
- agnostic therapy
- precision medicine

---
